据指数资本消息，10月17日，清锋科技（LuxCreo）宣布完成新一轮融资，本轮融资由时代天使战略投 资，指数资本担任独家财务顾问。同时，时代天使与清锋科技将建立全球战略合作关系，共同研发新一 代高性能隐形正畸3D打印材料。 ...

文｜胡香赟 编辑｜海若镜 36氪获悉，清锋科技（LuxCreo）近期完成新一轮融资，投资方为港股上市公司时代天使 （6699.HK）。双方将建立全球战略合作关系，共同开展新型3D打印材料研发、智能化平台迭代，以及 渠道和生态体系的建设。指数资本担任独家财务顾问。 清锋科技专注于提供聚合物3D打印解决方案，通过先进 3D 打印机及后处理系统、AI 智能化软件和高 性能材料的全面集成，打造从数据到终端产品的全套数字化生产解决方案。相关产品现已应用于齿科、 医疗、消费品和工业等多个领域。 近年来，伴随着大众口腔健康意识提升，全球隐形正畸市场持续增长，间接带动口腔医疗器械市场扩 容。国盛证券预测，到2030年时，全球口腔医疗器械市场规模将超过800亿美元。这个过程中，3D打 印、数字口腔等技术凭借提高治疗效率、改善患者治疗体验等优势，已深入渗透进口腔医疗服务的各个 环节。 其中，最具典型的应用案例之一就是隐形矫治器的制造。在数字化浪潮的推动下，直接3D打印正逐渐 被视为牙科产业的新一代核心技术，具备工序减少，制作周期短等优势。随着新型材料的不断突破和工 艺的进一步提升，3D直接打印矫治器的制造精度、力学性能和设计自由 ...

格隆汇10月16日丨根据联交所最新权益披露资料显示，2025年10月10日，时代天使(06699.HK)获JPMorgan Chase & Co.以每股均价61.5269港元增持好仓14.38 万股，涉资约884.76万港元。 增持后，JPMorgan Chase & Co.最新持好仓数目为24,032,210股，持好仓比例由13.98%上升至14.07%。 | 股份代號: | 06699 | | --- | --- | | 上市法國名稱: | 時代天使科技有限公司 | | 日期 (日 / 月 / 年): | 16/09/2025 - 16/10/202 | | 表格序號 | 大股東/董事/最高行政人員名稱作出披露的 買入 / 曹出或涉及的 每股的平均價 | | | | 持有權益的股份數目 佔已發行的 有關事件的日期 | | | --- | --- | --- | --- | --- | --- | --- | | | | | 股份數目 | | 語参國上述 * 註 | 有投票權股 (日 / 月 / 年) | | | | | | | | 份自分 标 | | | | | | | | 96 | | CS202510 ...

Group 1 - Morgan Stanley increased its stake in Times Angel (06699) by 143,800 shares at a price of HKD 61.5269 per share, totaling approximately HKD 8.8476 million [1] - After the increase, Morgan Stanley's total shareholding in Times Angel is approximately 24.0322 million shares, representing a stake of 14.07% [1]

Core Viewpoint - The company reported significant growth in overseas invisible aligner revenue, reaching approximately $71.7 million in H1 2025, a year-on-year increase of 123.4%, with case numbers surpassing domestic figures for the first time [1][2][5] Financial Performance - In H1 2025, the company achieved total revenue of $161 million, a 33.1% increase year-on-year, with adjusted net profit of $19.49 million, up 84.8% [1][3] - The net profit reached $14.17 million, reflecting a 583.6% increase, while the parent net profit was $14.64 million, a 362.7% rise [1][3] - The overall gross margin stood at 62.4%, consistent with the previous year, while the net margin improved by 7.1 percentage points to 8.8% [1][3] Regional Performance - The domestic market generated revenue of $89.7 million, showing a slight growth of 0.7%, with case numbers increasing by 14.0% to 108.6 thousand [2][3] - The overseas market's case numbers reached 117.2 thousand, a 103.5% increase, marking the first time it exceeded domestic case numbers [2][5] Product Performance - Revenue from invisible aligner solutions in mainland China was $86.23 million, a 2.1% increase, with case numbers growing by 14.0% [3] - Revenue from sales of invisible aligners outside mainland China was $70.99 million, a 122.3% increase, with case numbers also rising by 103.5% [3] Operational Efficiency - The company reported a significant reduction in operating losses in the overseas segment, from $16.7 million to $5.4 million, attributed to business scale expansion and delayed operational plans [1][2] - Sales and marketing expenses increased by 11.3% to $53.76 million, while the sales expense ratio decreased from 39.8% to 33.3% [3] Cash Position - As of June 30, 2025, the company had cash and cash equivalents totaling $344 million, with interest income and investment returns contributing $8.8 million to profits [4] Strategic Outlook - The company is focusing on expanding its international market presence, with plans to increase investments in sales, marketing, clinical support, and overseas production bases [7] - The global orthodontic market presents significant growth opportunities, with the company positioned as the second-largest provider of invisible aligners globally [4][5]

Core Insights - JPMorgan Chase increased its stake in Times Angel (06699) by approximately 73,688 shares at a price of about HKD 63.84 per share, totaling around HKD 4.7041 million [1] - Following this transaction, JPMorgan's total shareholding in Times Angel reached approximately 23.9217 million shares, representing a holding percentage of 14% [1]

Core Viewpoint - Morgan Stanley increased its stake in Times Angel (06699) by purchasing 73,688 shares at a price of HKD 63.838 per share, totaling approximately HKD 4.7041 million, raising its total holdings to about 23.9217 million shares, which represents a 14% ownership stake [1] Group 1 - Morgan Stanley's recent purchase indicates a bullish sentiment towards Times Angel, reflecting confidence in the company's future performance [1] - The total amount invested in this transaction was approximately HKD 4.7041 million, showcasing significant financial commitment [1] - Following the increase, Morgan Stanley's total shareholding in Times Angel reached approximately 23.9217 million shares [1]

Group 1 - JPMorgan Chase & Co. increased its stake in Times Angel (06699.HK) by acquiring 73,688 shares at an average price of HKD 63.838 per share, totaling approximately HKD 4.7041 million [1] - Following this acquisition, JPMorgan's total holdings in Times Angel rose to 23,921,655 shares, with the ownership percentage increasing from 13.96% to 14.00% [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 時代天使科技有限公司 呈交日期: 2025年10月8日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06699 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 500,000,000 | USD | | 0.0001 | USD | | 50,000 | | 增加 / 減少 (-) | | | | | | | USD | | | | 本月底結存 | | | 500,000,000 | USD | | 0.0001 | USD | | 50,000 | 本月底法定/註冊股本總額： ...

Group 1 - Morgan Stanley increased its stake in Times Angel (06699) by 124,350 shares at an average price of HKD 62.5004 per share, totaling approximately HKD 7.7719 million [1] - After the increase, Morgan Stanley's total shareholding in Times Angel is approximately 23,924,300 shares, representing a holding percentage of 14.01% [1]